The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Ende, G.
* Articles by Henn, F. A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Ende, G.
* Articles by Henn, F. A.
Related Collections
* Schizophrenia Spectrum Disorders
* MRS
Am J Psychiatry 158:1314-1316, August 2001
© 2001 American Psychiatric Association


Brief Report

Lower Concentration of Thalamic N-Acetylaspartate in Patients With Schizophrenia: A Replication Study

Gabriele Ende, Dr. rer. Nat., Dieter F. Braus, M.D., Sigrid Walter, Dipl. Phys., and Fritz A. Henn, M.D., Ph.D.

OBJECTIVE: Using proton magnetic resonance spectroscopic imaging, the authors measured thalamic N-acetylaspartate (NAA) concentrations in patients with schizophrenia. METHOD: The study included 15 schizophrenic patients on a stable medication regimen and 15 age-matched healthy comparison subjects. Concentrations of NAA, creatine plus phosphocreatine, and choline-containing compounds in bilateral thalamic regions were determined. RESULTS: Previous findings of lower NAA concentration in the left and right mediodorsal region of the thalamus and significant correlations between left and right thalamic NAA measures in patients with schizophrenia were corroborated. Furthermore, the concentrations of choline-containing compounds were significantly lower in the schizophrenic patients. No group differences in creatine plus phosphocreatine were found. CONCLUSIONS: There is strong evidence for neuronal dysfunction or loss in the mediodorsal region of the thalamus in patients with schizophrenia.




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
G. Ende, P. Hubrich, S. Walter, W. Weber-Fahr, N. Kammerer, D. F. Braus, and F. A. Henn
Further Evidence for Altered Cerebellar Neuronal Integrity in Schizophrenia
Am J Psychiatry, April 1, 2005; 162(4): 790 - 792.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. Theberge, Y. Al-Semaan, P. C. Williamson, R. S. Menon, R. W.J. Neufeld, N. Rajakumar, B. Schaefer, M. Densmore, and D. J. Drost
Glutamate and Glutamine in the Anterior Cingulate and Thalamus of Medicated Patients With Chronic Schizophrenia and Healthy Comparison Subjects Measured With 4.0-T Proton MRS
Am J Psychiatry, December 1, 2003; 160(12): 2231 - 2233.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
M. Kromkamp, H. B. M. Uylings, M. P. Smidt, A. J. C. G. M. Hellemons, J. P. H. Burbach, and R. S. Kahn
Decreased Thalamic Expression of the Homeobox Gene DLX1 in Psychosis
Arch Gen Psychiatry, September 1, 2003; 60(9): 869 - 874.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
E. V. Sullivan, M. J. Rosenbloom, K. L. Serventi, A. Deshmukh, and A. Pfefferbaum
Effects of Alcohol Dependence Comorbidity and Antipsychotic Medication on Volumes of the Thalamus and Pons in Schizophrenia
Am J Psychiatry, June 1, 2003; 160(6): 1110 - 1116.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org